If you can do the mental work to separate your sentiment about a stock from its recent price action, buying the dip in a recently dented winner can be a profitable investing strategy. Of course, it's key that you determine whether a business is experiencing a temporary setback or a more durable downturn before making the decision to buy. That can make the difference between buying the dip and making more money later, and buying the dip only to see your investment's value decline further. What's causing the ...

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Compass Minerals International, Inc. (NYSE: CMP) between November 29, 2023 and March 22, 2024, both dates inclusive (the "Class Period"), of the important June 24, 2024 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Compass Minerals securities during the Class Period you may be entitled to compensation without p ...

https://zlk.com/pslra-1/compass-minerals-lawsuit-submission-form?prid=83082&wire=3 CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) Compass Minerals overstated the likelihood that it would be awarded a renewed U.S. Forest Service contract for the use of its proprietary magnesium chloride-based aerial fire retardants for the 2024 fire season, as a result of safety issues presented by its fire retardant; (2) Compass Minerals materially overstated the e ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Compass Minerals International, Inc. ("Compass Minerals" or the "Company") (NYSE: CMP) investors that a class action has been filed on behalf of investors. Compass Minerals investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors who purchased and/or sold shares between November 29, 2023 and March 2 ...

On this news, Compass's stock price fell $3.00 per share, or 17.09%, to close at $14.55 per share on March 25, 2024. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz c ...

On this news, the price of Compass Minerals stock fell $3.00 per share, or 17.09%, to close at $14.55 on March 25, 2024. The next day, Compass Minerals stock fell a further $0.86 per share, or 5.9%, to close at $13.69. NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Compass Minerals International, Inc. ("Compass Minerals" or the "Company") (NYSE: CMP) and reminds investors of the June 24, 2024 deadline to see ...

NEW YORK, June 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Compass Minerals International, Inc. (NYSE: CMP). Shareholders who purchased shares of CMP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/compass-minerals-loss-submission-form/?id=82727&from=4 WHY GROSS LAW F ...

Fort Lauderdale, Florida--(Newsfile Corp. - May 30, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company")'s Vessel Brand ("Vessel"), renowned for its design and precision craftsmanship, proudly announces the release of Compass Rise. Built for the discerning connoisseur, Compass Rise embodies sophistication while delivering what consumers have come to expect from Vessel's products. From its sleek design, cutting-edge technology, and the ability to stay upright, every aspect of Compass Rise ref ...

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference taking place in New York City, NY June 5 – 6, 2024. Fireside Chat details Date: Wednesday, June 5, 2024 Time: 1:00 – 1:25 PM ET Webcast Link: https://wsw.com/jefferiesw ...

BOSTON, May 28, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that its Board of Directors has appointed Thomas Schuetz, M.D., Ph.D., President of Research and Development and Vice Chair of the Board of Directors of the Company, as President and Chief Executive Officer of the Company, effective May 28, 2024. Vered Bisker-Leib, P ...